Home › Atrial Fibrillation › Oklahoma
Atrial Fibrillation clinical trials in Oklahoma
8 studies for Atrial Fibrillation are looking for participants at sites in Oklahoma.
Cities in Oklahoma
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
- University of Oklahoma Health Sciences Center, Oklahoma City
RecruitingPhase 3
Ages 22 to 85 · All sexes · Updated Sep 30, 2026 · NCT05836987A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation
- Oklahoma Heart Hospital, Oklahoma City
Recruiting
Ages 18 to 80 · All sexes · Updated Sep 25, 2026 · NCT07527299Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
- Oklahoma Heart Hospital, Oklahoma City
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT04088071The Fourth Left Atrial Appendage Occlusion Study
- Saint Francis Hospital, Tulsa
Recruiting
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT05963698Detection of Atrial Fibrillation Using PPG From Smartphone Cameras
- CardioVascular Health Clinic, Oklahoma City
RecruitingObservational study
22 Minutes · All sexes · Updated Aug 21, 2026 · NCT07779213Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- Anthos Investigative Site 9917, Oklahoma City
RecruitingPhase 3
Ages 65 and older · All sexes · Updated Jul 13, 2026 · NCT05712200Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
- OU Medical Center, Oklahoma City
- Mercy Hospital Oklahoma City, Oklahoma City
- Ascension St. John Medical Center, Tulsa
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 8, 2026 · NCT03907046Dapagliflozin in Patients With Atrial Fibrillation (DAPA-AF)
- University of Oklahoma Health Sciences Center, Oklahoma City
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Apr 1, 2026 · NCT05174052From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.